Showing results (141-150 of 639) with videos related to
Sort By:
Pageof 64
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working GroupAlain Makinson, Vincent Le Moing, Jacques Reynes, et al.Medical Oncology (Northwood, London, England)|September 28, 2011
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinomaJean-Philippe Spano, Y Vano, S Vignot, et al.Cancers|February 25, 2022
Immune Reconstitution Inflammatory Syndrome Associated Kaposi SarcomaIsabelle Poizot-Martin, Sylvie Brégigeon, Romain Palich, et al.Cancer Treatment Reviews|June 22, 2016
A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancerThomas Seisen, Morgan Rouprêt, Florie Gomez, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 12, 2025
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung CancerAnne Opalikhin, Scott Friedland, Maria Lucia Madariaga, et al.La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancerArsela Prelaj, Rebecca Tay, Roberto Ferrara, et al.Bulletin Du Cancer|December 9, 2022
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]David Malka, Nicolas Girard, David M Smadja, et al.Pageof 64